AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Big Pharma's Rx to Rise and Shine.

The America's Intelligence Wire

| December 17, 2004 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From BusinessWeek Online)

Byline: Amy Tsao

Investors and insomniacs can rest easy: The Food & Drug Administration approved Lunesta, Sepracor's (SEPR) new drug for sleeplessness, on Dec. 15. Unlike rival drugs, including Sanofi-Aventis' (SNY) blockbuster Ambien, the new product has a label that doesn't warn against using it for longer than two weeks. Lunesta also claims another advantage: With Ambien, most troubled sleepers can get to sleep, but they often wake up in the middle of the night. The older sleep drugs, called benzodiazepines, pack a knock-out punch and can be addictive. According to David Southwell, Sepracor's chief financial officer, Lunesta "bridges the two" types of sleep aids.

Sepracor plans to back Lunesta with intense marketing and to play up data on safety and effectiveness from the six-month trial. The outfit says it will spend $60 million on consumer-marketing efforts…

Related articles from newspapers, magazines, journals, and more
Ambien CR is approved as newest sleeping aid.(developed by Sanofi-Aventis...
Magazine article from: Chain Drug Review September 26, 2005 700+ words
...Drug Administration approval for Ambien CR, a new version of its sleeping pill...sleep induction and maintenance. Ambien CR is available in a 12.5-mg dose...will compete with such products as Lunesta (Sepracor Inc.) and Rozzerem...
Sanofi-Aventis' Ambien "approvable".(Ambien CR approved)(Brief Article)
Newspaper article from: Pharma Marketletter April 18, 2005 700+ words
...Drug Administration relating to the group's sleep drug, Ambien CR (zolpidem tartrate controlled release), thereby delaying...firm Sepracor, which recently debuted its rival sleeping pill Lunesta (eszopiclone; Marketletters passim), pushing the group...
Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic...
Press release article from: PR Newswire January 4, 2008 700+ words
...results from a new study that showed Ambien CR(R) (zolpidem tartrate extended...disorder (GAD) compared to placebo. Ambien CR also improved sleep-related next...total sleep time in patients treated with Ambien CR and the antidepressant escitalopram...
Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia...
Press release article from: PR Newswire June 10, 2008 700+ words
Ambien CR(R) 12.5 mg significantly improved...results from a new study that showed Ambien CR(R) (zolpidem tartrate extended...Reuptake Inhibitor (SSRI) for depression. Ambien CR also improved sleep-related next...
AMBIEN CR(TM) Now Available in the U.S. for the Treatment of Insomnia.
Press release article from: PR Newswire October 7, 2005 700+ words
...EURONEXT: SAN) announced today that AMBIEN CR(TM) (zolpidem tartrate extended...States for the treatment of insomnia. AMBIEN CR(TM) is non-narcotic and a non...induction. In contrast to AMBIEN(R), AMBIEN CR(TM) is not limited to the short...
AMBIEN CR(TM) (Zolpidem Tartrate Extended-Release Tablets) CIV Receives FDA...
Press release article from: PR Newswire September 6, 2005 700+ words
...Drug Administration (FDA) has approved AMBIEN CR(TM) (zolpidem tartrate extended...CIV, for the treatment of insomnia. AMBIEN CR is non-narcotic and a non-benzodiazepine...maintenance, in addition to sleep induction. AMBIEN CR is the first and only extended-release...
New Data Show Improvements in Work Performance in Patients with Chronic...
Press release article from: PR Newswire October 24, 2007 700+ words
Study Confirms Role of AMBIEN CR in Effectively Managing Insomnia to...who were treated with 12.5 mg of AMBIEN CR(R) (zolpidem tartrate extended...evaluated the efficacy and safety of AMBIEN CR when taken as needed, were recently...
Ambien CR now available in the US for the treatment of insomnia.
News wire article from: Asia Africa Intelligence Wire October 7, 2005 700+ words
...Release) Sanofi-aventis announced that Ambien CR (zolpidem tartrate extended-release...the US for the treatment of insomnia. Ambien CR is non-narcotic and a non-benzodiazepine...sleep induction. In contrast to Ambien, Ambien CR is not limited to the short-term treatment...
Ambien CR (zolpidem tartrate extended-release tablets) CIV receives FDA...
News wire article from: Asia Africa Intelligence Wire September 6, 2005 700+ words
...Drug Administration (FDA) has approved Ambien CR (zolpidem tartrate extended-release...CIV, for the treatment of insomnia. Ambien CR is non-narcotic and a non-benzodiazepine...maintenance, in addition to sleep induction. Ambien CR is the first and only extended-release...
Ambien CR raises sleep time in insomnia with GAD.
Newspaper article from: Pharma Marketletter January 14, 2008 700+ words
...Aventis says that new study data showed Ambien CR (zolpidem tartrate extended-release...Total sleep time was increased in the Ambien CR group throughout the study. At week...0.0001). On average, those on Ambien CR fell asleep sooner and exhibited improved...
For more facts and information, see all results
©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily